[关于《中华人民共和国药典》（2005年版）一部中牡丹皮制剂质量控制的探讨]

[Discussion on quality control of preparations with cortex moutan in volume I pharmacopoeia of People's Republic of China (2005 edition)].

作者信息

Tian You-Qing, Ding Ping, Yan Xian-Hai, Hu Wen-Jiang

机构信息

Lianyungang Traditional Chinese Medicine Branch, Jiangsu Union Technical Institute, Lianyungang 222006, China.

出版信息

Zhongguo Zhong Yao Za Zhi. 2008 Feb;33(3):339-41.

PMID:18536477

Abstract

This article analyzed the quality control of 35 preparations with cortex moutan in volume I pharmacopoeia of People' s Republic of China (2005 edition). The result showed that only 11 preparations selected paeonol in cortex moutan as one of their quality indexes, the others selected other components or none as index. Via discussing problems on quality control in preparations with cortex moutan, it gave some suggestions on index selection for quality control and method selection for the determination of paeonol in preparations with cortex moutan, and provided some references for the revision of pharmacopoeia of People's Republic of China (2005 edition I ).

摘要

本文对《中华人民共和国药典》（2005年版）一部收载的35种含牡丹皮制剂的质量控制情况进行了分析。结果表明，仅11种制剂选用牡丹皮中丹皮酚作为质量指标之一，其他制剂则选用其他成分或未设指标。通过讨论含牡丹皮制剂质量控制中存在的问题，对含牡丹皮制剂质量控制指标的选择及丹皮酚含量测定方法的选择提出了建议，为《中华人民共和国药典》（2005年版一部）的修订提供参考。